Research and Markets: This Latest Report on Transdermal Drug Delivery's Technologies, Markets, and Companies is Now Availa

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/da2134/transdermal_drug_d) has announced the addition of Jain PharmaBiotech's new report "Transdermal Drug Delivery - Technologies, Markets, and Companies" to their offering.

This report deals with transdermal drug delivery - an approach used to deliver drugs through the skin for therapeutic use as an alternative to oral,intravascular, subcutaneous and transmucosal routes. Various transdermal drug delivery technologies are described including the use of suitable formulations, carriers and penetration enhancers. The most commonly used transdermal system is the skin patch using various types of technologies. Nanoparticles as well as the use of physical agents to facilitate transcutaneous drug delivery is described. Microneedle and needleless technologies are also described. Transdermal technologies may be applied for several categories of pharmaceuticals used for the treatment of disorders of the skin or for systemic effect to treat diseases of other organs. Several transdermal products and applications include hormone replacement therapy, contraception, management of pain, angina pectoris, smoking cessation and neurological disorders such as Parkinson's disease. The market for transdermal drug delivery is analyzed according to technologies and therapeutic areas from 2009 to 2019. This market is analyzed according to geographical regions as well.

Benefits of this report

  • Up-to-date one-stop information on transdermal drug delivery
  • Description of 117 companies involved and 100 collaborations in this area
  • Market analysis 2009-2019/
  • Market values in major regions
  • Strategies for developing markets for transdermal drug delivery
  • A selected bibliography of 170 publications
  • Text is supplemented by 17 tables and 10 figures

Who should read this report?

  • Biotechnology companies developing transdermal technologies
  • Drug delivery companies
  • Pharmaceutical companies interested in transdermal drug delivery
  • Pharmaceutical research institutes

Key Topics Covered:

1. Basics of Transdermal Drug Delivery

2. Transdermal Drug Delivery Technologies

3. Transdermal Therapeutics

4. Markets for Transdermal Drug Delivery

5. Companies involved in transdermal drug delivery

6. References

Author:

Professor K. K. Jain is a neurologist/neurosurgeon by training and has been working in the biotechnology/biopharmaceuticals industry for several years. He received graduate training in both Europe and USA, has held academic positions in several countries and is a Fellow of the Faculty of Pharmaceutical Medicine of the Royal Colleges of UK. Currently he is a consultant at Jain PharmaBiotech. Prof. Jain is the author of 415 publications including 16 books (2 as editor) and 48 special reports, which have covered important areas in biotechnology, gene therapy and biopharmaceuticals.

For more information visit http://www.researchandmarkets.com/research/da2134/transdermal_drug_d



CONTACT:

Research and Markets
Laura Wood, Senior Manager,
[email protected]
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

KEYWORDS:   Europe  Ireland

INDUSTRY KEYWORDS:   Health  Biotechnology  Pharmaceutical

MEDIA:

Logo
 Logo

Suggested Articles

The NIH is starting with Eli Lilly and AbCellera's COVID-19 antibody but could add more prospects as the trial goes on.

The series B positions ex-AveXis executives to build a biotech with a broad gene therapy pipeline and infrastructure to match.

A variant of the ACE2 receptor could work as a COVID-19 therapeutic by drawing the virus away from healthy cells, scientists reported.